ReviewTherapeutic advances in drug safety2016
Nonmedical prescribing: where are we now?
Review in Therapeutic advances in drug safety, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 69 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older.Annals of the rheumatic diseases · 2021Guideline
- Stakeholders' views and experiences of pharmacist prescribing: a systematic review.British journal of clinical pharmacology · 2018Pooled it
- A pilot randomised controlled trial of the Tailored Intervention for people with moderate-to-severe Chronic Obstructive Pulmonary Disease and Co-morbidities delivered by Pharmacists and Consultant respiratory Physicians (TICC-PCP).NPJ primary care respiratory medicine · 2025Trial
- Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial.Health expectations : an international journal of public participation in health care and health policy · 2022Trial
- Evaluation of a training programme for Pharmacist Independent Prescribers in a care home medicine management intervention.BMC medical education · 2022Trial
- Stakeholders' views of the implementation of pharmacist prescribing in the community pharmacy setting: a mixed-methods systematic review.Exploratory research in clinical and social pharmacy · 2026Review
- Beyond scope of practice: a prescribing autonomy framework to support early-career prescribers.International journal of clinical pharmacy · 2026Article
- Flight Forward or Rational Adaptation? Nurse Prescribing Through Herbert Simon's The Sciences of the Artificial.Nursing inquiry · 2026Article
- Exploring the current status of pharmacist prescribing in Middle Eastern Arab countries: a scoping review.International journal of clinical pharmacy · 2026Article
- Exploring the applicability of the UK Prescribing Safety Assessment with early career pharmacists as preparation before formal prescribing training.International journal of clinical pharmacy · 2026Article
- Exploring the Learning Experiences of Non-Medical Prescribing Among Podiatry Students on Clinical Placement.Journal of foot and ankle research · 2026Article
- A model-based cost-effectiveness analysis of prescribing by dietitians and therapeutic radiographers in England.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Pharmaceutical profile and prescribing practices in compounding pharmacies in Brazil: a cross-sectional study.Frontiers in pharmacology · 2026Article
- Prescription rights for psychologists - exploring professionals' perspective in Poland.Scientific reports · 2025Article
- Evaluating the Perceptions, Expectations, and Concerns of Community Pharmacists in Germany Regarding Prescribing by Pharmacists.Healthcare (Basel, Switzerland) · 2025Article
- A protocol for a pilot randomised controlled trial of a Tailored Intervention for people with moderate-to-severe Chronic Obstructive Pulmonary Disease and Co-morbidities delivered by Pharmacists and Consultant respiratory Physicians (TICC-PCP) in Scotland.Pilot and feasibility studies · 2025Article
- Exploring non-medical prescribing for patients with mental illness: a scoping review.BMC psychiatry · 2025Article
- Pharmacists' perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands.International journal of clinical pharmacy · 2025Article
- Clinical pharmacist prescriber in primary care in Slovenia: prospective non-randomised interventional study focused on clinical outcomes and quality of life.Frontiers in pharmacology · 2025Article
- Evaluating pharmacist independent prescribing for patients with mental illness in community care: a qualitative study.Frontiers in psychiatry · 2025Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issuedCorrigendum.2021
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonmedical prescribing has been allowed in the United Kingdom (UK) since 1992. Its development over the past 24 years has been marked by changes in legislation, enabling the progression towards independent prescribing for nurses, pharmacists and a range of allied health professionals. Although the UK has led the way regarding the introduction of nonmedical prescribing, it is now seen in a number of other Western-European and Anglophone countries although the models of application vary widely between countries. The programme of study to become a nonmedical prescriber (NMP) within the UK is rigorous, and involves a combination of taught curricula and practice-based learning. Prescribing is a complex skill that is high risk and error prone, with many influencing factors. Literature reports regarding the impact of nonmedical prescribing are sparse, with the majority of prescribing research tending to focus instead on prescribing by doctors. The impact of nonmedical prescribing however is important to evaluate, and can be carried out from several perspectives. This review takes a brief look back at the history of nonmedical prescribing, and compares this with the international situation. It also describes the processes required to qualify as a NMP in the UK, potential influences on nonmedical prescribing and the impact of nonmedical prescribing on patient opinions and outcomes and the opinions of doctors and other healthcare professionals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.